Thomas Arendt Nielsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas Arendt Nielsen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Aalborg University
1 shared publicationAnders K. Nielsen
Mech‐Sense Department of Gastroenterology & Hepatology Aalborg University Hospital Aalborg Denmark
1 shared publication- Asbjørn Mohr Drewes
Department of Gastroenterology & Hepatology, Aalborg University Hospital, Aalborg, Denmark
1 shared publication - Carina Graversen
Integrative Neuroscience, Department of Health Science and Technology, Aalborg University
1 shared publication - Carsten Dahl Mørch
Aalborg University
1 shared publication Mikkel Gram
Mech‐Sense Department of Gastroenterology & Hepatology Aalborg University Hospital Aalborg Denmark
1 shared publication
Latest Publications
- Open Access
- 20 November 2023
- Published by Aalborg University
The function of the autonomic nervous system in type 1 diabetes and in response to physiological and pharmacological modulations
- 20 November 2023
- Published by Aalborg University
Open AccessThe function of the autonomic nervous system in type 1 diabetes and in response to physiological and pharmacological modulations
- Open Access
- 20 November 2013
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 76 (6) , 951-963
A novel approach to pharmaco‐EEG for investigating analgesics: assessment of spectral indices in single‐sweep evoked brain potentials
To compare results from analysis of averaged and single-sweep evoked brain potentials (EPs) by visual inspection and spectral analysis in order to identify an objective measure for the analgesic effect of buprenorphine and fentanyl. Twenty-two healthy males were included in a randomized study to assess the changes in EPs after 110 sweeps of painful electrical stimulation to the median nerve following treatment with buprenorphine, fentanyl or placebo patches. Bone pressure, cutaneous heat and electrical pain ratings were assessed. EPs and pain assessments were obtained before drug administration, 24, 48, 72 and 144 h after beginning of treatment. Features from EPs were extracted by three different approaches: (i) visual inspection of amplitude and latency of the main peaks in the average EPs, (ii) spectral distribution of the average EPs and (iii) spectral distribution of the EPs from single-sweeps. Visual inspection revealed no difference between active treatments and placebo (all P > 0.05). Spectral distribution of the averaged potentials showed a decrease in the beta (12-32 Hz) band for fentanyl (P = 0.036), which however did not correlate with pain ratings. Spectral distribution in the single-sweep EPs revealed significant increases in the theta, alpha and beta bands for buprenorphine (all P < 0.05) as well as theta band increase for fentanyl (P = 0.05). For buprenorphine, beta band activity correlated with bone pressure and cutaneous heat pain (both P = 0.04, r = 0.90). In conclusion single-sweep spectral band analysis increases the information on the response of the brain to opioids and may be used to identify the response to analgesics.
- 20 November 2013
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 76 (6) , 951-963
Open AccessA novel approach to pharmaco‐EEG for investigating analgesics: assessment of spectral indices in single‐sweep evoked brain potentials
To compare results from analysis of averaged and single-sweep evoked brain potentials (EPs) by visual inspection and spectral analysis in order to identify an objective measure for the analgesic effect of buprenorphine and fentanyl. Twenty-two healthy males were included in a randomized study to assess the changes in EPs after 110 sweeps of painful electrical stimulation to the median nerve following treatment with buprenorphine, fentanyl or placebo patches. Bone pressure, cutaneous heat and electrical pain ratings were assessed. EPs and pain assessments were obtained before drug administration, 24, 48, 72 and 144 h after beginning of treatment. Features from EPs were extracted by three different approaches: (i) visual inspection of amplitude and latency of the main peaks in the average EPs, (ii) spectral distribution of the average EPs and (iii) spectral distribution of the EPs from single-sweeps. Visual inspection revealed no difference between active treatments and placebo (all P > 0.05). Spectral distribution of the averaged potentials showed a decrease in the beta (12-32 Hz) band for fentanyl (P = 0.036), which however did not correlate with pain ratings. Spectral distribution in the single-sweep EPs revealed significant increases in the theta, alpha and beta bands for buprenorphine (all P < 0.05) as well as theta band increase for fentanyl (P = 0.05). For buprenorphine, beta band activity correlated with bone pressure and cutaneous heat pain (both P = 0.04, r = 0.90). In conclusion single-sweep spectral band analysis increases the information on the response of the brain to opioids and may be used to identify the response to analgesics.